Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Inovio Pharmaceuticals has been awarded the US Department of Defense (DOD) Small Business Innovation Research Grant (SBIR) for examining the feasibility of delivering DNA vaccines by intradermal electroporation at the same time to two or more spatially distinct sites on the body.
Subscribe to our email newsletter
The research effort will seek to determine optimal spatial separation between vaccination sites on the body to avoid immune interference between multiple vaccines.
The final testing will involve delivery of Lassa and Hantaan virus vaccines simultaneously at spatially distinct sites.
Inovio president and CEO Joseph Kim said this device would provide a means to painlessly deliver multiple vaccines simultaneously, bringing improved protection against infectious diseases to both military and civilian populations.
"This collaboration builds on Inovio’s strong relationship with the US DOD, in which Inovio is bringing medical innovation to multiple bio-defense projects," Kim said.